{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:10:38Z","timestamp":1778181038144,"version":"3.51.4"},"reference-count":97,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited tumor syndrome, characterized by the development of multiple neuroendocrine tumors (NETs) in a single patient. Major manifestations include primary hyperparathyroidism, gastro-entero-pancreatic neuroendocrine tumors, and pituitary adenomas. In addition to these main NETs, various combinations of more than 20 endocrine and non-endocrine tumors have been described in MEN1 patients. Despite advances in diagnostic techniques and treatment options, which are generally similar to those of sporadic tumors, patients with MEN1 have a poor life expectancy, and the need for targeted therapies is strongly felt. MEN1 is caused by germline heterozygous inactivating mutations of the MEN1 gene, which encodes menin, a tumor suppressor protein. The lack of a direct genotype\u2013phenotype correlation does not permit the determination of the exact clinical course of the syndrome. One of the possible causes of this lack of association could be ascribed to epigenetic factors, including microRNAs (miRNAs), single-stranded non-coding small RNAs that negatively regulate post-transcriptional gene expression. Some miRNAs, and their deregulation, have been associated with MEN1 tumorigenesis. Recently, an extracellular class of miRNAs has also been identified (c-miRNAs); variations in their levels showed association with various human diseases, including tumors. The aim of this review is to provide a general overview on the involvement of miRNAs in MEN1 tumor development, to be used as possible targets for novel molecular therapies. The potential role of c-miRNAs as future non-invasive diagnostic and prognostic biomarkers of MEN1 will be discussed as well.<\/jats:p>","DOI":"10.3390\/ijms21207592","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T08:59:22Z","timestamp":1602665962000},"page":"7592","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome"],"prefix":"10.3390","volume":"21","author":[{"given":"Simone","family":"Donati","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1788-4426","authenticated-orcid":false,"given":"Simone","family":"Ciuffi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Marini","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8376-7404","authenticated-orcid":false,"given":"Gaia","family":"Palmini","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Miglietta","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Aurilia","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, University of Study of Florence, Viale Pieraccini 6, 50139 Florence, Italy"},{"name":"Unit of Bone and Mineral Diseases, University Hospital of Florence, Largo Palagi 1, 50139 Florence, Italy"},{"name":"Fondazione Italiana Ricerca Sulle Malattie Dell\u2019Osso (FIRMO Onlus), 50141 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Falchetti, A. (2017). Genetics of multiple endocrine neoplasia type 1 syndrome: What\u2019s new and what\u2019s old. F1000Res, 6.","DOI":"10.12688\/f1000research.7230.1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345666","article-title":"Multiple Endocrine Neoplasia Type 1","volume":"41","author":"Agarwal","year":"2013","journal-title":"Front. Horm. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-129-6-199809150-00011","article-title":"Multiple endocrine neoplasia type 1: Clinical and genetic topics","volume":"129","author":"Marx","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1172-1-38","article-title":"Multiple endocrine neoplasia type 1","volume":"1","author":"Marini","year":"2006","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Falchetti, A. (2010). Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): When and how. F1000 Med. Rep., 2.","DOI":"10.3410\/M2-14"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/qjmed\/89.9.653","article-title":"Clinical studies of multiple endocrine neoplasia type 1 (MEN1)","volume":"89","author":"Trump","year":"1996","journal-title":"QJM Int. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): Analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum. Mutat."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Marini, F., Cianferotti, L., and Brandi, M.L. (2016). Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17081329"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mce.2015.10.015","article-title":"Circulating microRNAs as novel biomarkers for bone diseases\u2014Complex signatures for multifactorial diseases?","volume":"432","author":"Hackl","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0587-8","article-title":"The role and mechanisms of action of microRNAs in cancer drug resistance","volume":"11","author":"Si","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"ref_12","first-page":"161","article-title":"The Role of MicroRNAs in Human Diseases","volume":"2","author":"Ardekani","year":"2010","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s12035-012-8374-6","article-title":"Big effects of small RNAs: A review of microRNAs in anxiety","volume":"47","author":"Hemmings","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"Hayder","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: Contributions of translational repression and mRNA decay","volume":"12","author":"Huntzinger","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nsmb.2931","article-title":"From guide to target: Molecular insights into eukaryotic RNA-interference machinery","volume":"22","author":"Ipsaro","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_17","unstructured":"(2020, September 20). miRBase. Available online: http:\/\/www.mirbase.org."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2015.09.002","article-title":"miRNA Nomenclature: A View Incorporating Genetic Origins, Biosynthetic Pathways, and Sequence Variants","volume":"31","author":"Desvignes","year":"2015","journal-title":"Trends Genet. TIG"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11102-010-0268-x","article-title":"MicroRNA profile indicates downregulation of the TGF\u03b2 pathway in sporadic non-functioning pituitary adenomas","volume":"14","author":"Butz","year":"2011","journal-title":"Pituitary"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ajpath.2011.07.002","article-title":"Silencing of the Imprinted DLK1-MEG3 Locus in Human Clinically Nonfunctioning Pituitary Adenomas","volume":"179","author":"Cheunsuchon","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1227\/NEU.0000000000000369","article-title":"MicroRNAs as biomarkers in pituitary tumors","volume":"75","author":"Butz","year":"2014","journal-title":"Neurosurgery"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Verdelli, C., and Corbetta, S. (2017). Epigenetic Alterations in Parathyroid Cancers. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020310"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/ERC-09-0134","article-title":"Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue","volume":"17","author":"Corbetta","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4251\/wjgo.v9.i9.341","article-title":"Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective","volume":"9","author":"Finnerty","year":"2017","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000487326","article-title":"A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors","volume":"107","author":"Malczewska","year":"2018","journal-title":"Neuroendocrinology"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Luzi, E., Marini, F., Giusti, F., Galli, G., Cavalli, L., and Brandi, M.L. (2012). The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the \u201cKnudson\u2019s second hit\u201d. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039767"},{"key":"ref_27","first-page":"1743","article-title":"Analysis of differentially expressed microRNAs in MEN1 parathyroid adenomas","volume":"9","author":"Luzi","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2008-14103","article-title":"Identification of miRNA changes in Alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways","volume":"14","author":"Cogswell","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gallo, A., Tandon, M., Alevizos, I., and Illei, G.G. (2012). The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030679"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The MicroRNA Spectrum in 12 Body Fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.7150\/ijbs.8.118","article-title":"Immune-related MicroRNAs are Abundant in Breast Milk Exosomes","volume":"8","author":"Zhou","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"ref_32","first-page":"71","article-title":"Cell-secreted vesicles in equine ovarian follicular fluid contain miRNAs and proteins: A possible new form of cell communication within the ovarian follicle","volume":"86","author":"Veeramachaneni","year":"2012","journal-title":"Biol. Reprod."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.tibs.2012.08.003","article-title":"Extracellular miRNAs: The mystery of their origin and function","volume":"37","author":"Turchinovich","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/ncomms4292","article-title":"HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells","volume":"5","author":"Tabet","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/bies.201500130","article-title":"Evidence and potential in vivo functions for biofluid miRNAs: From expression profiling to functional testing: Potential roles of extracellular miRNAs as indicators of physiological change and as agents of intercellular information exchange","volume":"38","author":"Iftikhar","year":"2016","journal-title":"Bioessays"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1373\/clinchem.2007.097972","article-title":"Detection and characterization of placental microRNAs in maternal plasma","volume":"54","author":"Chim","year":"2008","journal-title":"Clin. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","article-title":"Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma","volume":"141","author":"Lawrie","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2342860","article-title":"The Potential Role of miRNAs as New Biomarkers for Osteoporosis","volume":"2018","author":"Materozzi","year":"2018","journal-title":"Int. J. Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tcb.2011.12.001","article-title":"Secreted microRNAs: A new form of intercellular communication","volume":"22","author":"Chen","year":"2012","journal-title":"Trends Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Cui, M., Wang, H., Yao, X., Zhang, D., Xie, Y., Cui, R., and Zhang, X. (2019). Circulating MicroRNAs in Cancer: Potential and Challenge. Front Genet, 10.","DOI":"10.3389\/fgene.2019.00626"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1530\/ERC-17-0204","article-title":"The aberrantly expressed miR-372 partly impairs sensitivity to apoptosis in parathyroid tumor cells","volume":"25","author":"Verdelli","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12020-018-1551-2","article-title":"Verification of candidate microRNA markers for parathyroid carcinoma","volume":"60","author":"Hu","year":"2018","journal-title":"Endocrine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"12016","DOI":"10.1038\/s41598-018-30484-9","article-title":"Differential expression of miRNA199b-5p as a novel biomarker for sporadic and hereditary parathyroid tumors","volume":"8","author":"Hwang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1039\/C6MB00118A","article-title":"An autoregulatory network between menin and pri-miR-24-1 is required for the processing of its specific modulator miR-24-1 in BON1 cells","volume":"12","author":"Luzi","year":"2016","journal-title":"Mol. Biosyst."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00428-017-2158-3","article-title":"MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism","volume":"471","author":"Grolmusz","year":"2017","journal-title":"Virchows Arch."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"28379","DOI":"10.18632\/oncotarget.25357","article-title":"MicroRNA analysis of gastroenteropancreatic neuroendocrine tumors and metastases","volume":"9","author":"Zimmermann","year":"2018","journal-title":"Oncotarget"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/ERC-18-0244","article-title":"Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing","volume":"26","author":"Panarelli","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1530\/EJE-18-0305","article-title":"Prognostic relevance of proliferation-related miRNAs in pancreatic neuroendocrine neoplasms","volume":"179","author":"Grolmusz","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"ref_52","first-page":"2842","article-title":"Integrative microRNA-mRNA and protein-protein interaction analysis in pancreatic neuroendocrine tumors","volume":"20","author":"Zhou","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12022-019-9570-y","article-title":"MiRNA-3653 Is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine Tumours","volume":"30","author":"Gill","year":"2019","journal-title":"Endocr. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Klieser, E., Urbas, R., Swierczynski, S., St\u00e4ttner, S., Primavesi, F., J\u00e4ger, T., Mayr, C., Kiesslich, T., Fazio, P.D., and Helm, K. (2018). HDAC-Linked \u201cProliferative\u201d miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092781"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3748\/wjg.v24.i5.573","article-title":"Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1","volume":"24","author":"Dou","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"45462","DOI":"10.18632\/oncotarget.9990","article-title":"Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1","volume":"7","author":"Lloyd","year":"2016","journal-title":"Oncotarget"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1097\/MD.0000000000002224","article-title":"High expression of microRNA-196a indicates poor prognosis in resected pancreatic neuroendocrine tumor","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"B\u00f6sch, F., Bazhin, A.V., Heublein, S., Br\u00fcwer, K., Kn\u00f6sel, T., Reiter, F.P., Auernhammer, C.J., Guba, M.O., Spitzweg, C., and Werner, J. (2019). Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5794-y"},{"key":"ref_59","first-page":"624","article-title":"Glucose-induced microRNA-17 promotes pancreatic beta cell proliferation through down-regulation of Menin","volume":"19","author":"Lu","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1080\/15384101.2015.1064207","article-title":"Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors","volume":"14","author":"Raverot","year":"2015","journal-title":"Cell Cycle"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1507\/endocrj.EJ18-0487","article-title":"Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas","volume":"66","author":"He","year":"2019","journal-title":"Endocr. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s12020-019-01960-7","article-title":"Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN\/AKT, and STAT3 signaling pathways","volume":"65","author":"Grzywa","year":"2019","journal-title":"Endocrine"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Zhen, W., Du, Q., Zhiyong, C., Xin, W., Mengyao, J., Dimin, Z., Chonghui, H., Haijun, W., and Zhu, Y. (2017). MicroRNA-524-5p Functions as a Tumor Suppressor in a Human Pituitary Tumor-Derived Cell Line. Horm. Metab. Res., 49.","DOI":"10.1055\/s-0043-106437"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.canlet.2014.10.003","article-title":"MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5","volume":"356","author":"Renjie","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10528-017-9794-9","article-title":"Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile","volume":"55","author":"Wu","year":"2017","journal-title":"Biochem. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1159\/000485342","article-title":"MiR-148b, MiR-152\/ALCAM Axis Regulates the Proliferation and Invasion of Pituitary Adenomas Cells","volume":"44","author":"He","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/09168451.2019.1591260","article-title":"MicroRNA-543 promotes cell invasion and impedes apoptosis in pituitary adenoma via activating the Wnt\/\u03b2-catenin pathway by negative regulation of Smad7","volume":"83","author":"Shen","year":"2019","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Wang, D.S., Zhang, H.Q., Zhang, B., Yuan, Z.B., Yu, Z.K., Yang, T., Zhang, S.Q., Liu, Y., and Jia, X.X. (2016). miR-133 inhibits pituitary tumor cell migration and invasion via down-regulating FOXC1 expression. Genet. Mol. Res., 15.","DOI":"10.4238\/gmr.15017453"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.12659\/MSM.898908","article-title":"Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma","volume":"22","author":"Yu","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"ref_70","unstructured":"Yu, G., Wang, H., Yu, S., Li, C., Bai, J., Gui, S., Zhang, Y., and Zhao, P. (2017). Study on miRNAs\u2019 expression for the invasion of pituitary adenomas. Turk. Neurosurg."},{"key":"ref_71","first-page":"533","article-title":"Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis","volume":"42","author":"Wang","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Mart\u00ednez, A., L\u00f3pez-Mu\u00f1oz, B., Fajardo, C., C\u00e1mara, R., Lamas, C., Silva-Ortega, S., Aranda, I., and Pic\u00f3, A. (2020). Increased E2F1 mRNA and miR-17-5p Expression Is Correlated to Invasiveness and Proliferation of Pituitary Neuroendocrine Tumours. Diagnostics, 10.","DOI":"10.3390\/diagnostics10040227"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1007\/s13277-016-5155-2","article-title":"MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K\/AKT signaling pathway by targeting PTEN","volume":"37","author":"Zhou","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.12659\/MSM.900092","article-title":"Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K\/AKT","volume":"23","author":"Zheng","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11102-017-0805-y","article-title":"Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke\u2019s cell morphology","volume":"20","author":"Garbicz","year":"2017","journal-title":"Pituitary"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Lines, K.E., Newey, P.J., Yates, C.J., Stevenson, M., Dyar, R., Walls, G.V., Bowl, M.R., and Thakker, R.V. (2018). MiR-15a\/miR-16-1 expression inversely correlates with cyclin D1 levels in Men1 pituitary NETs. J. Endocrinol.","DOI":"10.1530\/JOE-18-0278"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1152\/ajpendo.00542.2013","article-title":"miR-24 regulates menin in the endocrine pancreas","volume":"307","author":"Vijayaraghavan","year":"2014","journal-title":"American Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ajpath.2016.10.021","article-title":"miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation","volume":"187","author":"Ehrlich","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_79","first-page":"2342","article-title":"miR-24 may be a negative regulator of menin in lung cancer","volume":"39","author":"Pan","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Li, S.-C., Khan, M., Caplin, M., Meyer, T., \u00d6berg, K., and Giandomenico, V. (2015). Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125553"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"77028","DOI":"10.18632\/oncotarget.20332","article-title":"Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000480121","article-title":"Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine","volume":"106","author":"Heverhagen","year":"2018","journal-title":"Neuroendocrinology"},{"key":"ref_83","first-page":"1235","article-title":"MicroRNA-16\/VEGFR2\/p38\/NF-\u03baB signaling pathway regulates cell growth of human pituitary neoplasms","volume":"39","author":"Lu","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"N\u00e9meth, K., Darvasi, O., Lik\u00f3, I., Sz\u00fccs, N., Czirj\u00e1k, S., Reiniger, L., Szab\u00f3, B., Krokker, L., P\u00e1llinger, \u00c9., and Igaz, P. (2019). Comprehensive analysis of circulating microRNAs in plasma of patients with pituitary adenomas. J. Clin. Endocrinol. Metab.","DOI":"10.1210\/jc.2018-02479"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"8516858","DOI":"10.1155\/2019\/8516858","article-title":"Identification of Serum miRNA-423-5p Expression Signature in Somatotroph Adenomas","volume":"2019","author":"Zhao","year":"2019","journal-title":"Int. J. Endocrinol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Kamilaris, C.D.C., and Stratakis, C.A. (2019). Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00339"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/15476286.2018.1445959","article-title":"Anti-miRNA oligonucleotides: A comprehensive guide for design","volume":"15","author":"Lima","year":"2018","journal-title":"RNA Biol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Zhao, H., Shen, J., Medico, L., Wang, D., Ambrosone, C.B., and Liu, S. (2010). A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013735"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Duttagupta, R., Jiang, R., Gollub, J., Getts, R.C., and Jones, K.W. (2011). Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020769"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1423-0127-20-72","article-title":"Circulating microRNAs have a sex-specific association with metabolic syndrome","volume":"20","author":"Wang","year":"2013","journal-title":"J. Biomed. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1093\/eurheartj\/eht007","article-title":"Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease","volume":"34","author":"Prins","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1160\/TH13-11-0977","article-title":"Smoking alters circulating plasma microvesicle pattern and microRNA signatures","volume":"112","author":"Badrnya","year":"2014","journal-title":"Thromb. Haemost."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3945\/an.111.001206","article-title":"MicroRNA, Nutrition, and Cancer Prevention1","volume":"2","author":"Ross","year":"2011","journal-title":"Adv. Nutr."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.4161\/rna.21619","article-title":"XenomiRs and miRNA homeostasis in health and disease","volume":"9","author":"Witwer","year":"2012","journal-title":"RNA Biol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Aoi, W., and Sakuma, K. (2014). Does regulation of skeletal muscle function involve circulating microRNAs?. Front. Physiol., 5.","DOI":"10.3389\/fphys.2014.00039"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Donati, S., Ciuffi, S., and Brandi, M.L. (2019). Human Circulating miRNAs Real-time qRT-PCR-based Analysis: An Overview of Endogenous Reference Genes Used for Data Normalization. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184353"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/20\/7592\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:21:14Z","timestamp":1760178074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/20\/7592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":97,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["ijms21207592"],"URL":"https:\/\/doi.org\/10.3390\/ijms21207592","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]}}}